Antipsychotic medication types
Pro Research Analysisby 
Searched over 200M research papers
Types of Antipsychotic Medications: First, Second, and Third Generation
Antipsychotic medications are mainly divided into three generations: first-generation (typical), second-generation (atypical), and third-generation antipsychotics. First-generation antipsychotics, also called typical antipsychotics or neuroleptics, were introduced in the 1950s and primarily block dopamine D2 receptors. Second-generation antipsychotics, or atypical antipsychotics, were developed later and target both dopamine and serotonin receptors, which generally results in fewer movement-related side effects but a higher risk of metabolic issues. Third-generation antipsychotics, such as aripiprazole, brexpiprazole, and cariprazine, act as partial dopamine agonists and are designed to balance dopamine activity rather than simply block it, aiming to reduce both movement and metabolic side effects Biso2025Orsolini2020Hardy2023+1 MORE.
Mechanisms of Action: Dopamine, Serotonin, and Beyond
Most antipsychotic drugs work by affecting neurotransmitter systems in the brain, especially dopamine and serotonin. First-generation antipsychotics mainly block dopamine D2 receptors, which helps control psychotic symptoms but can cause movement disorders. Second-generation antipsychotics block both dopamine and serotonin receptors, which helps reduce movement side effects but can increase the risk of weight gain and diabetes. Third-generation antipsychotics act as partial agonists at dopamine receptors, aiming to stabilize dopamine activity and reduce side effects. Newer investigational drugs are exploring other targets, such as glutamate, acetylcholine, cannabinoid receptors, enzyme inhibitors, and ion channel modulators, to improve treatment outcomes and reduce side effects Biso2025Orsolini2020Hardy2023+1 MORE.
Clinical Uses and Indications for Antipsychotic Medication Types
Antipsychotic medications are primarily used to treat schizophrenia and other psychotic disorders, but they are also prescribed for bipolar disorder, severe depression with psychotic features, and some behavioral disorders. Clozapine, a second-generation antipsychotic, is especially effective for treatment-resistant schizophrenia and has unique benefits, such as reducing suicide risk in schizophrenia patients. Some antipsychotics are also used for conditions like Tourette syndrome and as adjuncts in depression Sabella2017Thompson1994Lally2015+1 MORE.
Side Effects and Safety Profiles of Different Antipsychotic Types
First-generation antipsychotics are more likely to cause movement disorders, such as tremors and stiffness (extrapyramidal symptoms), while second-generation antipsychotics are more associated with weight gain, diabetes, and cholesterol problems. Third-generation antipsychotics generally have a better safety profile, with lower risks of both movement and metabolic side effects, but can still cause some adverse effects, including rare movement disorders and, as recent research shows, possible mitochondrial toxicity Orsolini2020Hardy2023Lally2015. The choice of medication often depends on balancing effectiveness with the risk of side effects for each individual.
Brain and Epigenetic Effects of Antipsychotic Medication Types
Antipsychotic medications can cause changes in brain structure, with typical antipsychotics more likely to increase the size of certain brain regions, such as the basal ganglia, compared to atypical antipsychotics. These changes are regional rather than global and may differ depending on the type of antipsychotic used . Additionally, antipsychotics can influence gene expression through epigenetic changes, such as DNA methylation and histone modification. For example, haloperidol is linked to increased DNA methylation, while clozapine tends to reduce it. Different antipsychotics also have unique effects on histone modifications, which may contribute to their therapeutic and side effect profiles .
Novel and Investigational Antipsychotic Medication Types
Recent research is focused on developing novel antipsychotics that target new pathways beyond dopamine and serotonin, such as glutamate, acetylcholine, and cannabinoid receptors. These investigational drugs aim to improve symptoms, especially negative and cognitive symptoms of psychosis, and reduce side effects. Some of these new compounds are showing promise in early trials and may be approved for use in the coming years Biso2025Orsolini2020Lally2015.
Conclusion
Antipsychotic medications are a diverse group of drugs with different mechanisms, uses, and side effect profiles. They are classified into first, second, and third generations, each with unique benefits and risks. Ongoing research is expanding the range of available treatments, targeting new pathways to improve effectiveness and safety for people with psychotic disorders and related conditions Biso2025Orsolini2020Hardy2023+1 MORE.
Sources and full results
Most relevant research papers on this topic